One Lab; Total Service. GTCR has acquired 40 organizations. We look forward to supporting Chip, Jim, and the Biocoat team as the Company continues its aggressive pursuit of follow-on acquisitions in the next chapter of its growth.". GTCR Chicago Private Equity Firm Our Team The Leaders Strategy Investments News Contact LP Login Search Watch Now A Leader in Private Equity for over 40 Years. We do this by using extraordinary people and flexible capital to help companies solve problems. This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. BofA Securities and Nomura Securities served as financial advisors and Kirkland & Ellis served as legal advisor to PathGroup. Existing Biocoat management and 1315 Capital, the selling equity sponsor, will retain minority stakes in the Company. In 2020, GTCR closed on its thirteenth equity fund, GTCR Fund XIII, with $7.5 billion of limited partner capital commitments. We are sorry for the inconvenience. GTCR - Investments, Portfolio & Company Exits - CrunchBase para nos informar sobre o problema. If you continue to see this The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services. All rights reserved. Over the past 15 months, we have made three Financial Services & Technology ("FS&T") platform investments: Optimal Blue, RevSpring and Sage Payment Solutions. We've known Dave King and Ben Davis for a long time and are excited to partner with them and support the Company in its next chapter of growth.". Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. We appreciate the support from Blackstone as we maintain our focus on these key constituents while growing the firms opportunity set., Mustafa M. Siddiqui, Head of Blackstones GP Stakes business said, GTCR has developed one of the most respected investment franchises in the private equity industry. Further information is available at www.blackstone.com. The Firms most common exit type is trade sale (49%). Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Growth Business Services, Healthcare, and Technology, Media & Telecommunications industries. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. paula.chirhart@blackstone.com, GTCR Contact: For press inquiries, contact[emailprotected]. Existing Biocoat management and 1315 Capital, the selling equity sponsor, will retain minority stakes in the Company. The Chicago-based firm pioneered The Leaders Strategy finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. How many investments has this organization made over time? GTCR Announces Recapitalization of PathGroup Prior to partnering with GTCR, Mr. Hance served as Chief Executive Officer of Creganna Medical, a leading supplier of contract manufacturing services for medical devices, where he significantly grew the business via acquisitions and organic growth before completing a successful sale of the company in 2016 to TE Connectivity. I have been personally gratified to develop rapport with the GTCR team, and we look forward to our long-term partnership., Ward Young, GP Stakes Managing Director added, Our top priority is to partner with the most successful general partners in private equity. For office-specific contact information, please visit our our offices page. GTCR LLC | 12,402 followers on LinkedIn. Our top priority at GTCR has always been to serve our limited partners by working to generate strong and consistent investment returns through the disciplined application of our investment strategy. Before that Jim played a leadership role in the growth and evolution of Wind Point Partners, a Chicago-based middle market private equity firm, over 19 years and five private equity funds. GTCR understands the dynamics of business transformation through acquisitions, consolidations and internal growth. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. 300 N. LaSalle Street, Suite 5600, For more information, please visitwww.gtcr.com. GTCR is based in Chicago with offices in New York and West Palm Beach. Going forward, the existing Biocoat management team, led by CEO Jim Moran, will continue in their existing roles executing on Biocoat's growth initiatives in partnership with GTCR. Revenue: $500 million to $1 billion (USD) Competitors: Allston Trading, Infinium Capital Management, Rothschild & Co. GTCR will also have access to a wide range of other services Blackstone provides internally and to its portfolio companies that leverage Blackstones scale and expertise, including its ESG, sustainability, human capital management, cybersecurity, and product development capabilities. Individual Investors & Financial Advisors. "Biocoat has an excellent track record of developing high-quality biocompatible medical coatings formulations using innovative technologies, and we look forward to investing additional capital to support both organic initiatives and strategic follow-on acquisitions in the medical coatings and broader biomaterials sector," said GTCR Managing Director Luke Marker. CHICAGO, Jan. 26, 2022 /PRNewswire/ -- GTCR, a leading private equity firm founded in 1980, today announced the recent closing of its first Strategic Growth Fund with $2 .0 billion of limited. Pritzker Private Capital and Vesey Street Capital Partners will also be retaining a minority ownership stake in the Company alongside GTCR and the PathGroup management team. Equity firm GTCR, formerly headed by Rauner, says it never owned By submitting this request, you consent to receive email from Blackstone. Contact:Kellie Kennedy312-933-4903kelliek@theharbingergroup.com, View original content to download multimedia:https://www.prnewswire.com/news-releases/gtcr-announces-investment-in-biocoat-301665671.html, Plus500. GTCR Closes $7.5 Billion Investment Fund - PR Newswire Chicago-based private equity firm GTCR is considering a sale of TerSera Therapeutics LLC that could value the specialty pharmaceutical company at more than $1 billion, according to people familiar . GTCR Announces Recapitalization of PathGroup To view recent press releases,click here. About PathGroupFounded in 1965, PathGroup is a premier provider of anatomic, clinical, molecular, and digital pathology services in the United States. Riverside Signs Definitive Agreement to Sell Lexipol Win whats next. Learn more at www.biocoat.com. Rauner makes it official, retires from GTCR, "Dealmakers' boot camp; Golder Thoma: A buyout industry proving ground", Personality Profile: Cressey Takes Specialization To The Next Level, Washington State Investment Board Private Equity IRR Report, Pennsylvania State Employee's Retirement System Detailed Holding Information, Private investment in public equity (PIPE), Taxation of private equity and hedge funds, Private equity and venture capital investors, https://en.wikipedia.org/w/index.php?title=GTCR&oldid=1130190495, Financial services companies established in 1980, Private equity firms of the United States, Articles with dead external links from December 2018, Articles with permanently dead external links, Creative Commons Attribution-ShareAlike License 3.0, This page was last edited on 29 December 2022, at 01:29.